Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Webcast ImageWebcast
Q4 2018 Charles River Laboratories International, Inc. Earnings Conference Call (Live)
02/13/19 at 8:30 a.m. ET
Webcast ImageWebcast
Charles River Laboratories International, Inc. at the J.P. Morgan Healthcare Conference (Replay)
01/08/19 at 1:00 p.m. ET
Webcast ImageWebcast
Charles River Laboratories International, Inc. at the J.P. Morgan Healthcare Conference - Q&A Session (Replay)
01/08/19 at 1:30 p.m. ET

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
01/17/19Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference CallPrinter Friendly Version
01/16/19Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality IndexPrinter Friendly Version
01/11/19Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug DiscoveryPrinter Friendly Version
01/07/19Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version
View More

Upcoming Events

DateTitle
02/13/19
8:30 a.m. ET
Q4 2018 Charles River Laboratories International, Inc. Earnings Conference Call
View More

Stock Quote

CRL (common)
Price
$118.81
Change (%)
+ 1.22 (1.04%)
Volume
265,012
Exchange
NYSE
Data as of 01/23/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)